LIST OF TABLES
TABLE 1. GLOBAL GENE THERAPY MARKET, BY VECTOR TYPE, 2020-2030,($MILLION)
TABLE 2. GENE THERAPY MARKET REVENUE, FOR VIRAL VECTOR, BY REGION , 2020-2030,($MILLION)
TABLE 3. GENE THERAPY MARKET VIRAL VECTOR BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. GENE THERAPY MARKET REVENUE, FOR NON VIRAL VECTOR, BY REGION , 2020-2030,($MILLION)
TABLE 5. GENE THERAPY MARKET NON VIRAL VECTOR BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. GLOBAL GENE THERAPY MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 7. GENE THERAPY MARKET REVENUE, FOR IN VIVO THERAPY, BY REGION , 2020-2030,($MILLION)
TABLE 8. GENE THERAPY MARKET IN VIVO THERAPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 9. GENE THERAPY MARKET REVENUE, FOR EX VIVO THERAPY, BY REGION , 2020-2030,($MILLION)
TABLE 10. GENE THERAPY MARKET EX VIVO THERAPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. GLOBAL GENE THERAPY MARKET, BY GENE TYPE, 2020-2030,($MILLION)
TABLE 12. GENE THERAPY MARKET REVENUE, FOR ANTIGEN, BY REGION , 2020-2030,($MILLION)
TABLE 13. GENE THERAPY MARKET ANTIGEN BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. GENE THERAPY MARKET REVENUE, FOR CYTOKINE, BY REGION , 2020-2030,($MILLION)
TABLE 15. GENE THERAPY MARKET CYTOKINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 16. GENE THERAPY MARKET REVENUE, FOR TUMOR SUPPRESSOR, BY REGION , 2020-2030,($MILLION)
TABLE 17. GENE THERAPY MARKET TUMOR SUPPRESSOR BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. GENE THERAPY MARKET REVENUE, FOR SUICIDE, BY REGION , 2020-2030,($MILLION)
TABLE 19. GENE THERAPY MARKET SUICIDE BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. GENE THERAPY MARKET REVENUE, FOR DEFICIENCY, BY REGION , 2020-2030,($MILLION)
TABLE 21. GENE THERAPY MARKET DEFICIENCY BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. GENE THERAPY MARKET REVENUE, FOR GROWTH FACTORS, BY REGION , 2020-2030,($MILLION)
TABLE 23. GENE THERAPY MARKET GROWTH FACTORS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. GENE THERAPY MARKET REVENUE, FOR RECEPTORS, BY REGION , 2020-2030,($MILLION)
TABLE 25. GENE THERAPY MARKET RECEPTORS BY COUNTRY, 2020-2030,($MILLION)
TABLE 26. GENE THERAPY MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 27. GENE THERAPY MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 28. GLOBAL GENE THERAPY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 29. GENE THERAPY MARKET REVENUE, FOR ONCOLOGICAL DISORDERS, BY REGION , 2020-2030,($MILLION)
TABLE 30. GENE THERAPY MARKET ONCOLOGICAL DISORDERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. GENE THERAPY MARKET REVENUE, FOR RARE DISEASES, BY REGION , 2020-2030,($MILLION)
TABLE 32. GENE THERAPY MARKET RARE DISEASES BY COUNTRY, 2020-2030,($MILLION)
TABLE 33. GENE THERAPY MARKET REVENUE, FOR NEUROLOGICAL DISORDERS, BY REGION , 2020-2030,($MILLION)
TABLE 34. GENE THERAPY MARKET NEUROLOGICAL DISORDERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 35. GENE THERAPY MARKET REVENUE, FOR OTHER DISEASES, BY REGION , 2020-2030,($MILLION)
TABLE 36. GENE THERAPY MARKET OTHER DISEASES BY COUNTRY, 2020-2030,($MILLION)
TABLE 37. GENE THERAPY MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 38. NORTH AMERICA GENE THERAPY MARKET, BY VECTOR TYPE, 2020-2030,($MILLION)
TABLE 39. NORTH AMERICA GENE THERAPY MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 40. NORTH AMERICA GENE THERAPY MARKET, BY GENE TYPE, 2020-2030,($MILLION)
TABLE 41. NORTH AMERICA GENE THERAPY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 42. NORTH AMERICA GENE THERAPY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 43. U.S. GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 44. U.S. GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 45. U.S. GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 46. U.S. GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 47. CANADA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 48. CANADA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 49. CANADA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 50. CANADA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 51. MEXICO GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 52. MEXICO GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 53. MEXICO GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 54. MEXICO GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 55. EUROPE GENE THERAPY MARKET, BY VECTOR TYPE, 2020-2030,($MILLION)
TABLE 56. EUROPE GENE THERAPY MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 57. EUROPE GENE THERAPY MARKET, BY GENE TYPE, 2020-2030,($MILLION)
TABLE 58. EUROPE GENE THERAPY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 59. EUROPE GENE THERAPY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 60. GERMANY GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 61. GERMANY GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 62. GERMANY GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 63. GERMANY GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 64. FRANCE GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 65. FRANCE GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 66. FRANCE GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 67. FRANCE GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 68. U.K. GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 69. U.K. GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 70. U.K. GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 71. U.K. GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 72. ITALY GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 73. ITALY GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 74. ITALY GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 75. ITALY GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 76. SPAIN GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 77. SPAIN GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 78. SPAIN GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 79. SPAIN GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 80. REST OF EUROPE GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 81. REST OF EUROPE GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 82. REST OF EUROPE GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 83. REST OF EUROPE GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 84. ASIA-PACIFIC GENE THERAPY MARKET, BY VECTOR TYPE, 2020-2030,($MILLION)
TABLE 85. ASIA-PACIFIC GENE THERAPY MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 86. ASIA-PACIFIC GENE THERAPY MARKET, BY GENE TYPE, 2020-2030,($MILLION)
TABLE 87. ASIA-PACIFIC GENE THERAPY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 88. ASIA-PACIFIC GENE THERAPY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 89. JAPAN GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 90. JAPAN GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 91. JAPAN GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 92. JAPAN GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 93. CHINA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 94. CHINA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 95. CHINA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 96. CHINA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 97. AUSTRALIA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 98. AUSTRALIA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 99. AUSTRALIA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 100. AUSTRALIA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 101. INDIA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 102. INDIA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 103. INDIA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 104. INDIA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 105. SOUTH KOREA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 106. SOUTH KOREA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 107. SOUTH KOREA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 108. SOUTH KOREA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 109. REST OF ASIA PACIFIC GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 110. REST OF ASIA PACIFIC GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 111. REST OF ASIA PACIFIC GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 112. REST OF ASIA PACIFIC GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 113. LAMEA GENE THERAPY MARKET, BY VECTOR TYPE, 2020-2030,($MILLION)
TABLE 114. LAMEA GENE THERAPY MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 115. LAMEA GENE THERAPY MARKET, BY GENE TYPE, 2020-2030,($MILLION)
TABLE 116. LAMEA GENE THERAPY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 117. LAMEA GENE THERAPY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 118. BRAZIL GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 119. BRAZIL GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 120. BRAZIL GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 121. BRAZIL GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 122. SAUDI ARABIA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 123. SAUDI ARABIA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 124. SAUDI ARABIA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 125. SAUDI ARABIA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 126. SOUTH AFRICA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 127. SOUTH AFRICA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 128. SOUTH AFRICA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 129. SOUTH AFRICA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 130. REST OF LAMEA GENE THERAPY MARKET BY VECTOR TYPE 2020-2030,($MILLION)
TABLE 131. REST OF LAMEA GENE THERAPY MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 132. REST OF LAMEA GENE THERAPY MARKET BY GENE TYPE 2020-2030,($MILLION)
TABLE 133. REST OF LAMEA GENE THERAPY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 134.: COMPANY SNAPSHOT
TABLE 135.: OPERATING SEGMENTS
TABLE 136.: PRODUCT PORTFOLIO
TABLE 137.: NET SALES,
TABLE 138.: KEY STRATERGIES LIST OF FIGURES
FIGURE 1.GENE THERAPY MARKET SEGMENTATION
FIGURE 2.GENE THERAPY MARKET,2020-2030
FIGURE 3.GENE THERAPY MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.GENE THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.GENE THERAPY MARKET,BY VECTOR TYPE,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF VIRAL VECTOR GENE THERAPY MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NON VIRAL VECTOR GENE THERAPY MARKET,2020-2030(%)
FIGURE 14.GENE THERAPY MARKET,BY THERAPY,2020(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF IN VIVO THERAPY GENE THERAPY MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF EX VIVO THERAPY GENE THERAPY MARKET,2020-2030(%)
FIGURE 17.GENE THERAPY MARKET,BY GENE TYPE,2020(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ANTIGEN GENE THERAPY MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CYTOKINE GENE THERAPY MARKET,2020-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF TUMOR SUPPRESSOR GENE THERAPY MARKET,2020-2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SUICIDE GENE THERAPY MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DEFICIENCY GENE THERAPY MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF GROWTH FACTORS GENE THERAPY MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF RECEPTORS GENE THERAPY MARKET,2020-2030(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS GENE THERAPY MARKET,2020-2030(%)
FIGURE 26.GENE THERAPY MARKET,BY APPLICATION,2020(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ONCOLOGICAL DISORDERS GENE THERAPY MARKET,2020-2030(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF RARE DISEASES GENE THERAPY MARKET,2020-2030(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL DISORDERS GENE THERAPY MARKET,2020-2030(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHER DISEASES GENE THERAPY MARKET,2020-2030(%)
FIGURE 31.GENE THERAPY MARKET BY REGION,2020
FIGURE 32.U.S. GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 33.CANADA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 34.MEXICO GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 35.GERMANY GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 36.FRANCE GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 37.U.K. GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 38.ITALY GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 39.SPAIN GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 40.REST OF EUROPE GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 41.JAPAN GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 42.CHINA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 43.AUSTRALIA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 44.INDIA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 45.SOUTH KOREA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 46.REST OF ASIA PACIFIC GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 47.BRAZIL GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 48.SAUDI ARABIA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 49.SOUTH AFRICA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 50.REST OF LAMEA GENE THERAPY MARKET,2020-2030($MILLION)
FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 55.COMPETITIVE DASHBOARD
FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 57..: NET SALES ,($MILLION